About
David Scadden, M.D., has served as a member of the Agios board of directors since June 2017. He is an independent director, a member of the Nominating and Governance Committee, and chair of the Science and Technology Committee.
Dr. Scadden is the Gerald and Darlene Jordan Professor of Medicine at Harvard University. He founded and directs the Center for Regenerative Medicine at Massachusetts General Hospital, co-founded and co-directs the Harvard Stem Cell Institute, and is chairman and professor of the Harvard University Department of Stem Cell and Regenerative Biology. He has also served on the board of scientific counselors for the National Cancer Institute, the board of external experts for the National Heart, Lung and Blood Institute, and the board of directors of the International Society for Stem Cell Research.
Roles
Agios Pharmaceuticals, Inc.
Director · Current role
May 2017–present
Harvard University
Gerald and Darlene Jordan Professor of Medicine · Co-founder and co-director of the Harvard Stem Cell Institute.
2006 – present
Massachusetts General Hospital
Physician; founder, Center for Regenerative Medicine · Directed the Hematologic Malignancies Center of the MGH Cancer Center for 10 years.
1995 – present
External Roles
Fate Therapeutics
Scientific founder
—
Lightning Biotherapeutics
Director
—
Harvard University
Gerald and Darlene Jordan Professor of Medicine; Chairman, Department of Stem Cell and Regenerative Biology
—
Massachusetts General Hospital
Founder and Director, Center for Regenerative Medicine
—
Harvard Stem Cell Institute
Co-Founder and Co-Director
—
Editas Medicine, Inc.
Board of Directors; Organization, Leadership and Compensation and Science and Technology Committees
—
Lightning Biotherapeutics
Board of Directors
—
Sonata Therapeutics
Board of Directors
—
Director Compensation
FY 2025
Fees earned or paid in cash
$70,000
Also at Agios Pharmaceuticals, Inc.